Discover how much money can be saved in your clinical trial!

Verified Clinical Trials Research Subject DatabaseTo Stop Dual Enrollment And Study Scavenger To Attend At Patients As Partners Conference

Verified Clinical Trials To Attend Patients As Partners

Verified Clinical Trials the research subject database to stop dual enrollment in clinical trials provides services for clinical trial compliance and research subject engagement.  Verified Clinical Trials will attend the Patients As Partners ConferenceMarch 3rd & 4th in Philadelphia.  Verified Clinical Trials is partnered with many of the world’s leading pharmaceutical companies , CROs, and research sites to improve clinical trial safety and data quality while improving the research subject’s clinical trial experience.

Study Scavenger will also attend the conference.  Study Scavenger is the first multilingual smartphone app that has been launched to meet research subject’s individual and personal needs.  Study Scavenger allows the subject to utilize the fastest growing technology platform in the mobile world to determine which studies may be right for them by choosing study parameters and stipends that meet their needs.

Sponsors have a greater than ever commitment to partner with patients, but the reality is there are limitations and barriers – such as HIPAA, to name just one of many. What are some of the best strategies, programs, technologies and ideas to overcome the limitations and barriers?  Patients as Partners takes a broad view of the patient experience and how we engage with patients across the entire clinical trial continuum. This includes early research, patient-centric protocol design, recruitment, retention, engagement, and communicating results with patients acting as ambassadors and educators.

The conference is designed for clinical trial executives in pharma and biotech, directors in patient advocacy and academia, and service providers who are looking to incorporate the patient perspective throughout the clinical trial process, valuing patients and treating them as partners, ultimately leading to more successful clinical trials.